Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Both immature and mature fat cells are important for hair growth cycles, with immature cells promoting growth and mature cells possibly inhibiting it.

Plant root hair growth is controlled by the hormone auxin, which affects the production of certain oxygen-related molecules through a specific process.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Nilotinib can cause generalized keratosis pilaris.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

New hair regrowth therapies show promise but need more research.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Prostaglandin E2 promotes skin cancer, but certain supplements and drugs may help reduce risk and improve treatment.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Baricitinib is a promising treatment for alopecia areata.

Hyaluronate fragments can help reverse skin thinning by working with the CD44 receptor.

α-Phellandrene may help prevent hair loss by increasing growth factors and cell growth in hair cells through a specific signaling pathway.